行情

FBIO

FBIO

Fortress Biotech
NASDAQ

实时行情|Nasdaq Last Sale

1.850
+0.110
+6.32%
交易中 15:05 12/10 EST
开盘
1.720
昨收
1.740
最高
1.860
最低
1.690
成交量
20.19万
成交额
--
52周最高
2.590
52周最低
0.4900
市值
1.30亿
市盈率(TTM)
-2.0285
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

FBIO 新闻

  • 5 Stocks Moving On ASH Presentations
  • Benzinga.1天前
  • Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
  • GlobeNewswire.1天前
  • The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
  • Benzinga.3天前
  • The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
  • Benzinga.3天前

更多

所属板块

制药
+0.72%
制药与医学研究
+0.70%

热门股票

名称
价格
涨跌幅

FBIO 简况

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
展开

Webull提供Fortress Biotech Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。